Shares of Moderna jumped by a staggering 27.73% in 30 days from $131.61 to $168.10 at 23:14 EST on Thursday, after two consecutive sessions in a row of gains. NASDAQ Composite is dropping 0.94% to $13,818.41, following last session’s downward trend,
Moderna’s last close was $169.50, 12.59% below its 52-week high of $189.26.
Moderna’s sales growth is 26009.7% for the current quarter and 6199.3% for the next. The company’s growth estimates for the present quarter and the next is 842.9% and 1948.4%, respectively.
Year-on-year quarterly revenue growth grew by 3960.8%, now sitting on 803.4M for the twelve trailing months.
Moderna’s Stock Yearly Top and Bottom Value
Moderna’s stock is valued at $168.10 at 23:14 EST, way under its 52-week high of $189.26 and way above its 52-week low of $30.98.
Moderna’s Moving Average
Moderna’s worth is way above its 50-day moving average of $143.54 and way above its 200-day moving average of $119.02.
More news about Moderna.